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STUDIES HAVE SHOWN THAT HEPATITIS B VIRUS (HBV)
is not a cytopathic virus against liver cells. This can
be seen in healthy carriers, that although there are
lots of HBV particles in the liver cells, there is no
pathological disorder in the liver tissues. The HBV
infection is caused mainly by the immunological
reaction of the carrier’s against the liver cells infected
by HBV.1,2
The clinical manifestations of the infection de-
pend very much on its immunological reaction, par-
ticularly the cellular immunological reaction against
HBV. If there is none or only minimum immunological
reaction, the carrier will be healthy. Acute B hepatitis
will occur if the immunological reaction causes liver
cell necrosis followed by the disappearance of HBV
from the liver cells. When the immunological reaction
does not succeed to destroy HBV from  the liver cells,
there will be a chronic hepatitis. When the necrosis on
the chronic B hepatitis is wide, it will become aggres-
sive chronic, and if there is only little necrosis, there
will be persistent chronic B hepatitis.3-5  This paper re-
ports our study on humoral and cellular responses of
persistent infection of HBV will be discussed.
Methods
The random sampling took children of 6-14 years old
in Semarang Municipality. In perspective, there were
children with persistent and non persistent hepatitis
B. The research planning used perspective method
for finding the persistent of HBV as a subject. The
immunological factors examined were humoral
immunity in the form of IgM anti-HBc, and Anti HBs.
There was no anti-HBe nor anti-Pre S1 neither Pre
S2 examination conducted. The cellular immunity
examined was the total number of lymphocyte cells,
CMI skin test, the number of T cells, T helper and T
suppressor, as well as the CD4/CD8 cell ratio.
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The immunological variables consisted of variables of skin
test, T rosette cell, CD4 cell, CD8, ratio of CD4/CD8 and
specific function of T cytotoxic cell. The skin test variable
was the skin test using CMI multitest from Paris and it is
called positive if in 2x24 hours the diameter of indurations
is >2 mm. The T cell variable was the T cell in rosette
form and was examined by using T rosette method. The
variable of CD4 cell is T helper cell examined by using
ELISA in % unit. The variable of CD8 cell was T suppressor
cell or T cytotoxic cell which was examined by using ELISA
in % unit. The variable function of cytotoxic cell was T
cytotoxic cell examined by MIF method.
The analysis between the risk factors and the
persistent HBV used the controlled study method.
The statistical analysis was conducted by using t test
and Chi-square.
Results
IgM Anti HBc examination was administered to 203
children having positive HBsAg, and it turned out
that all children show negative IgM  Anti-HBc. In
this research, there was not much symptom on children
having positive HBsAg, or in other words these
children were HBsAg asymptomatic carriers. Also,
when their blood was taken for the test, none of them
was having acute HBV infection. The IgM anti HBc
examination was conducted to differentiate acute
hepatitis and chronic hepatitis.(6) Brunetto et al.
(1993) stated that IgM anti-HBc was useful for
diagnosis and supervision of chronic hepatitis B.(7)
The result of the examination of cellular immunity
response included the result of a) CMI skin test,  b)
T lymphocyte cell, c) CD4 cell, d) CD8 cell, e) ratio
of CD4/CD8 and f) specific function of cytotoxic T
cell against pure HBsAg.
CMI Skin Test
Table 1  shows the relationship of CMI skin test and
persistent HBV infection on children.
TABLE 1. RELATIONSHIP OF SKIN TEST AND PERSISTENT
HBV INFECTION
CMI SkinTest HBV Infection Total
Persistent Nonpersistent
n % n % n
Negative 40 35.1 31 34.8 71 35
Positive 74 64.9 58 65.2 132 65
Total 114 56.2 89 43.8 203 100
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  mean = 73.6%      mean = 75.7%
               p = 0.035
Figure 1. T Lymphocyte cell on persistent HBV infection and non persistent ones.
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Figure 2. Number of CD4 cells on persistent and non persistent HBV infection on children
Figure 3.  The total average of CD8 cells on persistent and non persistent HBV infection on children.
Figure 4. The average of CD4/CD8 ratio on persistent and non persistent HBV infection on children.
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Table 1 shows that out of 203 children having skin test,
71 children (35%) were negative and 132 (65%) were
positive.  Positive skin test on persistent children was
64.9% and on non persistent 65.2%, while negative skin
test on persistent ones was 35.1% and on non persistent
ones is 34.8%. By statistical analysis chi square, there was
no significant relationship between skin test and HBV
infection on persistent children (p>0.05).
T Lymphocyte Cell
Figure 1 shows some difference on average  number
of T lymphocyte cell of persistent HBV infected
children and the non persistent ones. Figure 1 shows
that the average number of T cells on persistent HBV
infection was less than the non persistent ones and
statistically significant (p<0.05). This shows that if
the T lymphocyte cell was increasing, then the cellular
immunity response function would be more active, so
that the increasing T lymphocyte cell would cause
the HBsAg destroyed and disappeared. This research
shows that the number of T lymphocyte cell was
decreasing, meaning that the cell number for cellular
immunity was also decreasing, so that the percentage
of persistent was increasing.
T Helper Cell or CD4 Cell
The difference between CD4 cell on HBV on
persistent and non persistent children can be seen on
Figure 2.
Figure 2  shows that there was a difference on average
number of CD4 cells on persistent and non persistent
HBV infection on children (p<0.001). Total number
of CD4 cells on persistent ones were higher than the
non persistent ones, this indicated that if CD4 cells
was increasing, the persistency was also increasing.
This was due to that the CD4 cells has a function to
regulate the immunoregulation or even suppress the
anti virus response.(8)
T Cytotoxic Cell (CD8 Cell)
The difference of total average of CD8 cells on
persistent and non persistent HBV infection on
children can be seen in Figure 3. Figure 3  shows that
there was no significant difference between the total
number of CD8 cells on persistent and non persistent
HBV infection on children (p>0.05). If has been
known that the T cytotoxic cell has a very important
role in the damage of liver cells on hepatitis B.
Ratio of CD4/CD8
Figure 4 shows the difference between the ratio of CD4/
CD8  and the persistent and non persistent HBV
infection on children. Figure 4 shows that there was
no significant difference between the average of CD4/
CD8 ratio and the persistent and non persistent HBV
infection on children (p>0,05). If the CD4/CD8 ratio
is more than 1, it will cause the infection to be persistent,
and if it is less than 1, it will decrease the persistency.
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Figure 5. The function of specific T cell on persistent and non persistent HBV infection on children.
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This is because the number of T cytotoxic cells will be
increasing and the CD4/CD8 ratio becomes less than
1. In this case, the CD4/CD8 ratio has no relationship
with the HBV infection persistency.
The Function of Specific T Cell
The difference between specific T cytotoxic cell
function and persistent and non persistent HBV
infection on children is shown on Figure 5. Figure 5
shows that there was no significant difference between
the function of specific T cell on persistent and non
persistent HBV infection on children (p>0.05).
Migration inhibition factor (MIF) test is conducted by
using pure HBsAg as the antigen.  From this test, there
was no difference observed between the group of
children having persistent and non persistent infection.
Discussion
There are two things required to cure HBV infection,
i.e.: The first is the cellular immune response which is
effective to destroy the infected liver cells.  The second
is the humoral neutralizing antibody which can prevent
the spreading of the virus which flee into the other
liver cells which are still healthy.  When there is any
disturbance in either one or both the two mechanisms
above, the infection will become persistent.(5)
It has been known that there are several impor-
tant antigen systems against the HBV infection,
namely: HBsAg, HBcAg and HBeAg, and these three
antigen will cause humoral immunity response of the
body, namely Anti-HBs, Anti-HBc and Anti-HBe.
However, the result of the research shows that the
persistent group had no Anti-HBs formed yet and all
the groups had negative Anti-HBc, so that they could
not be differentiated statistically.
Anti pre S1 and anti pre S2 were not examined,
and latter it is known that HBsAg consists of S, pre
S1, and pre S2 components, which will form anti S or
anti HBs, anti pre S1 and anti pre S2. Research con-
ducted by Neurath et al (9) shows that the
immunodominant epitope of HBsAg is located in pro-
tein pre-S, and in pre S2 to be precise. It has been
proofed that the binding site of HBsAg is located in
pre-S2.(9)  In the recovery process of acute hepatitis B,
before the anti-HBs appears, the first one appears is
anti pre-S2. Some researches show that both on acute
and chronic hepatitis, pre-S2 is the indicator of the
HBV disappearance or the recovery from HBV infec-
tion. Anti pre-S2 is not found on acute hepatitis B
which tends to be chronic, and is not found on chronic
hepatitis B.(1)
Research shows that Anti-pre S is the neutraliz-
ing antibody released during HBV infection. Anti-pre
S has the role as the starter in the recovery process of
HBV infection. This antibody is the first antibody in
the recovery stage. And the titer of Anti-pre S was
decreasing along with the disappearance of HBsAg.(1,5)
The result of the cellular immunity examination
was that the CMI skin test shown no significant dif-
ference.  The negative result of skin test on persis-
tent HBsAg shows that on persistent HBsAg of 35.1%,
the cellular immunity is generally low. This condition
is caused by various situations, the growth of the im-
mature immune cells, the status of nutrition, calory
and protein or other vitamin. This is also stated by
Stites (1991) that chronic infection will cause the
decrease of cellular immunity. (10) Lack of calory and
protein also decreases the cellular immunity.(11)
The conclusion is that the T lymphocyte cell has
the role as the risk factor of persistent HBV infection
on children. This is the same as the research con-
ducted by Dinfeng et al (1980) which found out that
the T cell is decreasing on all hepatitis groups exam-
ined, particularly on fulminant hepatitis and active
chronic hepatitis, which cause the recovery percent-
age is decreasing and becomes persistent.(12)
Figures 1 and 2 show the total number of T cells
and CD4 cells on persistent and non persistent HBV
which are different significantly in statistic (p<0.01).
This shows that total number of T cell in general on
persistent hepatitis B is less than the non persistent
ones, so that the function to eliminate the virus is
also lessening, the CD4 cells show that the
immunoregulation function and immune response re-
pression is still enough and different between the per-
sistent and non persistent ones.
In this research, the specific T cytolytic cell
function against HBsAg has no significant difference
(p>0.05). This is probably due to the antigen used
for the MIF test is pure HBsAg, but does not use
HBcAg, since in persistent hepatitis, the target anti-
gen is HBcAg  or HBeAg.  If the MIF test is normal,
this means that the T cell function is good and there
is no liver cells damage. The damage of liver cells is
caused by immunological response against the liver
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cells infected by HBV which cause the target anti-
gen appears on the cell membrane. (12,13) On acute
hepatitis, the target antigen is HBsAg. (14) In this case,
the one having the important role is the T cytolytic
cell which is capable of identifying the HBV antigen
created on the cell membrane.(15) Dienstag (1984)
found that the liver cells damage was caused by the
effort of the body to eliminate the HBV.(13) This is in-
fluenced by several factors such as the existence of
anti HBc in the circulation, imunoregulator in the
serum, and the role of HLA class I. The T cytolytic
cell can identify the target antigen, if the target anti-
gen is created and appears along with the HLA class
I. On chronic hepatitis B, it is often that there is no
HLA class I on the cell membrane, so that the im-
mune cellular system can not touch the cells infected
by HBV, which creates HBV antigen on the cell sur-
face.(14) It is understandable that the individuals on
this research are children having persistent HBV in-
fection whose MIF test is normal, since actually the
cellular immune response against the HBV particle
in vitro is probably still normal, while if it is in vivo, the
result could be different. Besides, on chronic HBV
infection, the target antigen created on the cell mem-
brane is HBcAg or HBeAg, and not HBsAg.
The conclusion of this research about the im-
munological aspect of persistent HBV as follows. The
result of humoral immunity examination in this re-
search of Ig Anti-HBc has been all negative.
Cellular immunity examination in this research such
as CMI skin test is not significant difference (p>0.05),
T cell examination show significant statistically
difference (p<0.01), CD4 examination also significant
different (p<0.01), CD8, CD4/CD8 ratio and the
specific function of cytotoxic T cell show no
significant difference (p>0.05).
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